These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22932454)

  • 1. [Neuroendocrine neoplasm of digestive system with different grades: a clinicopathologic and prognostic study].
    Zhang MH; Liu YH; Luo XL; Lin XT; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):448-51. PubMed ID: 22932454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathological features of colorectal neuroendocrine neoplasms and prognostic significance of WHO staging system].
    Zhang XH; Lu XL; Wu N; Liu B; Wang FY; Zhang RS; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):191-6. PubMed ID: 23769440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic significance and grading of stromal invasion in pT1 adenocarcinoma of lung].
    Xu Y; Zhou XJ; Dong YC; Ma HH; Lu ZF; He Y
    Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):451-5. PubMed ID: 19781191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
    Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
    Yao W; Wang W; Li G
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.
    Özaslan E; Demir S; Karaca H; Güven K
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on clinicopathologic grading system and prognosis of primary hepatic neuroendocrine neoplasms].
    Zhao J; Yang B; Xu C; Zhang WS; Ji Y; Chen LL; Tan YS; Zeng HY; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):102-6. PubMed ID: 22455886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic features and prognostic analysis of 104 patients with gastric neuroendocrine neoplasms].
    Liang W; Gao Y; Li J; Cui J; Xi H; Cai A; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Apr; 19(4):427-31. PubMed ID: 27112478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53, KI-67, CD117 expression in gastrointestinal and pancreatic neuroendocrine tumours and evaluation of their correlation with clinicopathological and prognostic parameters.
    Kımıloğlu Şahan E; Erdoğan N; Ulusoy İ; Samet E; Akyıldız İğdem A; Gönüllü D
    Turk J Gastroenterol; 2015 Mar; 26(2):104-11. PubMed ID: 25835106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastrointestinal and pancreatic neuroendocrine tumors: a clinicopathologic and immunohistochemical study].
    Sun LM; Qiu XS; Wang EH
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):696-7. PubMed ID: 23302313
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
    Wang X; Song ZF; Yao WX; Pan CC; Xiang MF; Wang H
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1411-4. PubMed ID: 24025507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
    Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate analysis of metastasis‑related risk factors for patients with gastroenteropancreatic neuroendocrine tumors based on clinicopathological and endoscopic features.
    Tang C; Gong L; Zou W; Zhang J; Zhou Y; Wu X; Lu F; Ouyang C; Liu X
    Oncol Rep; 2016 Dec; 36(6):3343-3352. PubMed ID: 27748940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
    Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
    Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chinese pathologic consensus for standard diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasm].
    Chinese Pathologic Consensus Group for Gastrointestinal and Pancreatic Neuroendocrine Neoplasm
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):257-62. PubMed ID: 21616002
    [No Abstract]   [Full Text] [Related]  

  • 16. Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome.
    Panzuto F; Merola E; Rinzivillo M; Partelli S; Campana D; Iannicelli E; Pilozzi E; Mercantini P; Rossi M; Capurso G; Scarpa A; Cascinu S; Tomassetti P; Falconi M; Delle Fave G
    Pancreas; 2014 Mar; 43(2):212-8. PubMed ID: 24518498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluation of cases with gastroenteropancreatic neuroendocrine tumors between 2004 and 2012 according to the 2010 criteria.
    Ozkara S; Aker F; Yesil A; Senates E; Canbey C; Yitik A; Gonen C
    Hepatogastroenterology; 2013 Oct; 60(127):1665-72. PubMed ID: 24627925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
    Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of neuroendocrine differentiation in T3-T4 node-negative colorectal cancer.
    Cho YB; Yang SS; Lee WY; Song SY; Kim SH; Shin HJ; Yun SH; Chun HK
    Int J Surg Pathol; 2010 Jun; 18(3):201-6. PubMed ID: 19372085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung).
    Kim SJ; Kim JW; Oh DY; Han SW; Lee SH; Kim DW; Im SA; Kim TY; Heo DS; Bang YJ
    Am J Clin Oncol; 2012 Dec; 35(6):549-56. PubMed ID: 21659833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.